Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.50 |
| ▸ | MAG | P20916 | 4/20 | 0.39 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.39 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.39 |
| ▸ | NEU2 | Q9Y3R4 | 2/20 | 0.39 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.39 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SELL | P14151 | 1/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30484530 | 0.90 | NANP (0.49) | NANPMAGNEU4NEU3NEU2 | |
| SCHEMBL31695272 | 0.88 | NANP (0.39) | NANPMAGSIGLEC7L3MBTL1SELL | |
| SCHEMBL31695026 | 0.87 | NANP (0.48) | NANPNEU4NEU3NEU2SIGLEC7 | |
| SCHEMBL15090252 | 0.87 | NANP (0.48) | NANPNEU4NEU3NEU2SIGLEC7 | |
| SCHEMBL16362518 | 0.87 | NANP (0.48) | NANPNEU4NEU3NEU2SIGLEC7 | |
| SCHEMBL15087687 | 0.82 | NANP (0.58) | NANPMAGSIGLEC7SELLSELP | |
| SCHEMBL18357290 | 0.82 | NANP (0.58) | NANPMAGSIGLEC7SELLSELP | |
| SCHEMBL16839997 | 0.82 | NANP (0.58) | NANPMAGSIGLEC7SELLSELP | |
| SCHEMBL24630166 | 0.81 | NANP (0.58) | NANPMAGNEU4NEU3NEU2 | |
| SCHEMBL21162637 | 0.81 | NANP (0.58) | NANPMAGNEU4NEU3NEU2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797946-B1 | SIALIC ACID DIMERS | BROSSMER REINHARD (DE) | 2016-05-04 | — | — | EP | disclosed |
| US-9260467-B2 | Sialic acid dimers | BROSSMER REINHARD (DE) | 2016-02-16 | — | — | US | disclosed |
| US-9260467-B2 | Sialic acid dimers | BROSSMER REINHARD (DE) | 2016-02-16 | — | — | US | disclosed |
| US-20150005245-A1 | Sialic Acid Dimers | BROSSMER REINHARD (DE) | 2015-01-01 | — | — | US | disclosed |
| US-20150005245-A1 | Sialic Acid Dimers | BROSSMER REINHARD (DE) | 2015-01-01 | — | — | US | disclosed |
| WO-2013097942-A1 | SIALIC ACID DIMERS | BROSSMER REINHARD (DE) | 2013-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005245-A1 | Sialic Acid Dimers | SIGLEC9, SIGLEC7, NEU2 | NANP 333/4885MAG 503/4885NEU4 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.